Guardant Health Wins $292.5 Million in Landmark False Advertising Case Against Rival Natera

San Francisco, California – In a decisive courtroom victory, Guardant Health, a prominent manufacturer of medical diagnostics, was awarded $292.5 million in damages on Monday. This followed a federal jury’s verdict that competitor Natera had engaged in false advertising concerning its colorectal cancer screening tests. The case, which captured industry and public attention, centered on accusations that Natera’s claims about its tests were misleading, thereby negatively impacting Guardant Health’s market standing and reputation. The substantial award consisted of both actual and punitive damages, highlighting the severity of the claims. This legal battle signifies a pivotal … Read more

Jury Awards Guardant Health $292.5 Million in False Advertising Case Against Rival Natera

San Francisco, CA – A federal jury in California delivered a significant verdict favoring Guardant Health in a legal battle against Natera Inc., awarding the medical test manufacturer a substantial $292.5 million in damages. The jury found that Natera had engaged in false advertising regarding its colorectal cancer test, which it claimed was superior to Guardant Health’s Reveal test. The decision arrived after a contentious legal confrontation, underscoring the fierce competition within the biotechnology sector, particularly in the development and marketing of cancer diagnostic tests. This lawsuit highlights the critical role of accurate and truthful … Read more